These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 9673387

  • 1. Matrix metalloproteinase expression in human breast cancer: an immunohistochemical study including correlation with cathepsin D, type IV collagen, laminin, fibronectin, EGFR, c-erbB-2 oncoprotein, p53, steroid receptors status and proliferative indices.
    Ioachim EE, Athanassiadou SE, Kamina S, Carassavoglou K, Agnantis NJ.
    Anticancer Res; 1998; 18(3A):1665-70. PubMed ID: 9673387
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E, Kamina S, Demou A, Kontostolis M, Lolis D, Agnantis NJ.
    Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
    Ioachim EE, Goussia AC, Machera M, Tsianos EV, Kappas AM, Agnantis NJ.
    Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
    [Abstract] [Full Text] [Related]

  • 4. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer.
    Ioachim E, Kamina S, Athanassiadou S, Agnantis NJ.
    Anticancer Res; 1996; 16(5B):3141-7. PubMed ID: 8920782
    [Abstract] [Full Text] [Related]

  • 5. Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices.
    Ioachim EE, Malamou-Mitsi V, Kamina SA, Goussia AC, Agnantis NJ.
    Anticancer Res; 2000; 20(6B):4221-5. PubMed ID: 11205251
    [Abstract] [Full Text] [Related]

  • 6. Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer.
    Rudolph P, Alm P, Olsson H, Heidebrecht HJ, Fernö M, Baldetorp B, Parwaresch R.
    Hum Pathol; 2001 Mar; 32(3):311-9. PubMed ID: 11274641
    [Abstract] [Full Text] [Related]

  • 7. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
    Eissa S, Khalifa A, el-Gharib A, Salah N, Mohamed MK.
    Anticancer Res; 1997 Mar; 17(2B):1417-23. PubMed ID: 9137508
    [Abstract] [Full Text] [Related]

  • 8. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, Sneige N.
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [Abstract] [Full Text] [Related]

  • 9. Tumor growth fraction, expression of estrogen and progesterone receptors, p53, bcl-2 and cathepsin D activity in primary ductal invasive breast carcinoma and their axillary lymph node metastases.
    Kristek J, Dmitrović B, Kurbel S, Sakić K, Krajinović Z, Blazicević V, Has B, Marjanović K.
    Coll Antropol; 2007 Dec; 31(4):1043-7. PubMed ID: 18217456
    [Abstract] [Full Text] [Related]

  • 10. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N, Moriya T, Suzuki T, Kimura M, Ohuchi N, Satomi S, Sasano H.
    Anticancer Res; 2000 Dec; 20(2B):1101-8. PubMed ID: 10810403
    [Abstract] [Full Text] [Related]

  • 11. Correlations of morphology, proliferation indices, and oncogene activation in ductal breast carcinoma: nuclear grade, S-phase, proliferating cell nuclear antigen, p53, epidermal growth factor receptor, and c-erb-B-2.
    Dabbs DJ.
    Mod Pathol; 1995 Aug; 8(6):637-42. PubMed ID: 8532697
    [Abstract] [Full Text] [Related]

  • 12. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
    Rudolph P, Olsson H, Bonatz G, Ratjen V, Bolte H, Baldetorp B, Fernö M, Parwaresch R, Alm P.
    J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
    [Abstract] [Full Text] [Related]

  • 13. Tumour epidermal growth factor receptor, erbB-2 and cathepsin D in node-negative invasive breast cancer: their impact on the selection of patients for systemic adjuvant therapy.
    Tonkin KS, McKay JW, Stitt LW, Tokmakejian S, Haines DS.
    Cancer Prev Control; 1999 Apr; 3(2):131-6. PubMed ID: 10474760
    [Abstract] [Full Text] [Related]

  • 14. Expression of cathepsin D in urothelial carcinoma of the urinary bladder: an immunohistochemical study including correlations with extracellular matrix components, CD44, p53, Rb, c-erbB-2 and the proliferation indices.
    Ioachim E, Charchanti A, Stavropoulos N, Athanassiou E, Bafa M, Agnantis NJ.
    Anticancer Res; 2002 Apr; 22(6A):3383-8. PubMed ID: 12530091
    [Abstract] [Full Text] [Related]

  • 15. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer.
    Eissa S, Khalifa A, el-Gharib A, Salah N, Mohamed MK.
    Anticancer Res; 1997 Apr; 17(4B):3091-7. PubMed ID: 9329609
    [Abstract] [Full Text] [Related]

  • 16. Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients.
    Aryandono T, Harijadi, Ghozali A.
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():600-6. PubMed ID: 10895217
    [Abstract] [Full Text] [Related]

  • 17. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
    Umemura S, Takekoshi S, Suzuki Y, Saitoh Y, Tokuda Y, Osamura RY.
    Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712
    [Abstract] [Full Text] [Related]

  • 18. Caveolin-1 is down-regulated and inversely correlated with HER2 and EGFR expression status in invasive ductal carcinoma of the breast.
    Park SS, Kim JE, Kim YA, Kim YC, Kim SW.
    Histopathology; 2005 Dec; 47(6):625-30. PubMed ID: 16324201
    [Abstract] [Full Text] [Related]

  • 19. Simultaneous quantitative analyses of c-erbB-2 protein, epidermal growth factor receptor, cathepsin D, and hormone receptors in breast cancer.
    Iwase H, Itoh Y, Kuzushima T, Yamashita H, Iwata H, Toyama T, Hara Y, Kobayashi S.
    Cancer Detect Prev; 1997 Dec; 21(1):29-35. PubMed ID: 9043760
    [Abstract] [Full Text] [Related]

  • 20. Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer.
    Horak E, Smith K, Bromley L, LeJeune S, Greenall M, Lane D, Harris AL.
    Oncogene; 1991 Dec; 6(12):2277-84. PubMed ID: 1685017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.